Seasonal influenza continues to be one of the most common, and serious health conditions seen worldwide that even stands as a leading cause of mortality. The need for rapid critical diagnosis thus prevails, pushing the growth of rapid influenza diagnostic testing (RIDT) market. One of the recent studies of Fairfield Market Research focuses on the growth prospects of global rapid influenza diagnostic testing market over the next few years. Adoption of RIDT as a preferred point-of-care testing (POCT) form has been on the rise over the recent past, which is expected to largely contribute to market growth. The accuracy, and faster outcome of rapid influenza diagnostic testing also will remain the critical growth contributor for market. With the diagnostics sector poised for a flourishing growth outlook, demand for rapid influenza diagnostic testing will also thrive. The report suggests that paediatrics will be an important segment for RIDT market players.
Get Exclusive PDF Sample Copy Of This Report@ https://www.fairfieldmarketresearch.com/report/rapid-influenza-diagnostic-testing-ridt-market/request-sample
Demand for RIDT Received a Dramatic Push amid COVID-19 Pandemic
While influenza A and B prevalence remains on an all-time high, it has also been responsible for the recent epidemics such as avian/bird flu. This highlights the need for an effective diagnostic measure, as well as early treatment against all the flu variants. The constant quest for a specific, reliable treatment will remain the key factor accelerating adoption of rapid influenza diagnostic testing methods. COVID-19 pandemic particularly generated robust demand for RIDT for its higher specificity, faster outcome, convenient usage, and greater sensitivity. Hospitals, and diagnostic centres continue to record consumption at healthy rates, thereby favouring the growth of rapid influenza diagnostic testing market. Striking resemblance between the symptoms of flue, and COVID-19 initially gave a solid push to flu testing.
North America Dominant, Sales of RIDT Kits Prominent in Asia Pacific
There has been a lot of effort from governments in North America toward public education, and awareness about flu diagnosis, and treatment. While this will continue to drive North American market for rapid influenza diagnostic testing, predominant technology penetration in the US is also likely to be an important factor fuelling market growth here. The region houses a dynamic research field that also favours the growth of market. Both the US, and Canada witness a notably high number of hospitalisation cases each year, creating revenue generation opportunities for RIDT market participants. Asia Pacific on the other hand holds high-value opportunities according to initial report findings. Besides increasing prevalence of flu, this market will benefit from the growth of high-risk elderly population. RIDT kits continue to gain traction in key Asian markets.
Key Competitors in Rapid Influenza Diagnostic Testing Market
Hologic, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Abbott Laboratories, GenMark Diagnostics, Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Quidel Corporation, Luminex Corporation, Meridian Bioscience, Inc., Biocartis, bioMérieux Inc., and Endress+Hauser (Analytik Jena AG) constitute some of the prominent companies driving competition in global rapid influenza diagnostic testing market. Fairfield Market Research intends to shed light on the detailed competitive profiling in the report that would help existing, and potential competitors in RIDT market landscape.
Check Complete Report Details of market @ https://www.fairfieldmarketresearch.com/report/rapid-influenza-diagnostic-testing-ridt-market/request-sample
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn
0
